Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
Saposhnikovia divaricata extract is a botanical product derived from the roots of the *Saposhnikovia divaricata* plant, a staple in traditional Chinese medicine known as Fangfeng. It possesses significant anti-inflammatory, antioxidant, and analgesic properties. Recent research indicates its potential in treating ulcerative colitis by inhibiting ferroptosis—a form of regulated cell death—through the modulation of the p53/SLC7A11/GPX4 signaling axis. Specifically, the extract down-regulates p53 expression while up-regulating the cystine/glutamate transporter (SLC7A11) and glutathione peroxidase 4 (GPX4), leading to reduced oxidative stress and proinflammatory cytokine levels.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Follow clinical development from study design and recruitment through results.
Explore development by indication, patient population, and geography.
Trace asset ownership, licensing agreements, and commercial partnerships.
Explore the patent landscape and regulatory exclusivity around an asset.
Compare development programs by target, modality, and indication.
Connect source evidence and development news to your research questions.
See how Gosset can support your research on saposhnikovia divaricata extract.